Cerebrospinal fluid levels of transition metals in patients with Alzheimer's disease
The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Abstract
We compared CSF and serum levels of iron, copper, manganese, and zinc, measured by atomic absorption spectrophotometry, in 26 patients patients with Alzheimer's disease (AD) without major clinical signs of undernutrition, and 28 matched controls. CSF zinc levels were significantly decreased in AD patients as compared with controls (p < 0.05). The serum levels of zinc, and the CSF and serum levels of iron, copper, and manganese, did not differ significantly between AD-patient and control groups. These values were not correlated with age, age at onset, duration of the disease, and scores of the MiniMental State Examination in the AD group. Weight and body mass index were significantly lower in AD patients than in controls. Because serum zinc levels were normal, the possibility that low CSF zinc levels were due to a deficiency of dietary intake seems unlikely. However, it is possible that they might be related to the interaction of beta-amyloid and/or amyloid precursor protein with zinc, that could result in a depletion of zinc levels.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Molina et al. (91) examined 26 AD and 28 control subjects and found a significant decrease in cerebrospinal fluid zinc levels in AD patients.”
From Discovery of Human Zinc Deficiency: Its Impact on Human Health and Disease (2013) · cites this paper as [91]
Citations
Cites
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282 · cited 1×
“Evaluation of each patient included: anamnesis and neurological examination, Mini-Mental State Examination ( Folstein et al., 1975 ), Hachinski Ischemic Score (Hachinski et al., 1975), Hamilton’s Rating Scale for depression (Hamilton, 1969), and laboratory tests (blood cell count, urinalysis, blood routine biochemistr…”
MethodHamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915 · cited 1×
“B) Criteria for “probable AD” according to the NINCDS-ADRDA Work Group criteria ( McKahnn et al., 1984 ).”
Method. Cerebral blood flow in dementia.
Hachinski, V. C., Iliff, L. D., Zilhka, E., Du Boulay, G. H., McAllister, V. L., Marshall, J., Russell, R. W. R., & Symon, L. (1975) · Archives of Neurology · doi:10.1001/archneur.1975.00490510088009 · Cited by 3,186 · cited 2×
“Evaluation of each patient included: anamnesis and neurological examination, Mini-Mental State Examination (Folstein et al., 1975), Hachinski Ischemic Score (Hachinski et al., 1975), Hamilton’s Rating Scale for depression (Hamilton, 1969), and laboratory tests (blood cell count, urinalysis, blood routine biochemistry…”
MethodDEXTER, D. T., CARAYON, A., JAVOY-AGID, F., AGID, Y., WELLS, F. R., DANIEL, S. E., LEES, A. J., JENNER, P., & MARSDEN, C. D. (1991) · Brain · doi:10.1093/brain/114.4.1953 · Cited by 1,043
Oxygen radicals and the nervous system
Halliwell, B., & Gutteridge, J. M. C. (1985) · Trends in Neurosciences · doi:10.1016/0166-2236(85)90010-4 · Cited by 819 · cited 1×
“Iron (Halliwell and Gutteridge, 1988), copper (Halliwell and Gutteridge, 1985), and manganese (Donaldson et al., 1992) act as prooxidant agents.”
BackgroundThe Amyloid Precursor Protein of Alzheimer's Disease in the Reduction of Copper(II) to Copper(I)
Multhaup, G., Schlicksupp, A., Hesse, L., Beher, D., Ruppert, T., Masters, C. L., & Beyreuther, K. (1996) · Science · doi:10.1126/science.271.5254.1406 · Cited by 678
Deibel, M. A., Ehmann, W. D., & Markesbery, W. R. (1996) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(96)00203-1 · Cited by 540 · cited 3×
“There have been described decreased copper concentrations in the hippocampus and amygdala (Deibel et al., 1996).”
BackgroundGood, P. F., Perl, D. P., Bierer, L. M., & Schmeidler, J. (1992) · Annals of Neurology · doi:10.1002/ana.410310310 · Cited by 476 · cited 1×
“Iron levels have been described to be increased in the hippocampus (Morris et al., 1994; Deibel et al., 1996), amygdala (Deibel et al., 1996) frontal cortex (Kala et al., 1996; Loeffler et al., 1995), globus pallidus (Loeffler et al., 1995) and cerebellum (Kala et al., 1996), and it has been described accumulation of…”
BackgroundA Selective Increase in Particulate Superoxide Dismutase Activity in Parkinsonian Substantia Nigra
Saggu, H., Cooksey, J., Dexter, D., Wells, F. R., Lees, A., Jenner, P., & Marsden, C. D. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb11759.x · Cited by 454 · cited 2×
“constituents of the cytosolic Cu/Zn- and the mitochondrial Mn-superoxide dismutases, respectively, which could protect against oxidative processes (Marttila et al., 1988; Saggu et al., 1989).”
Background
Cited by
Discovery of Human Zinc Deficiency: Its Impact on Human Health and Disease
Prasad, A. S. (2013) · Advances in Nutrition · doi:10.3945/an.112.003210 · Cited by 919
Metal dyshomeostasis and oxidative stress in Alzheimer’s disease
Greenough, M. A., Camakaris, J., & Bush, A. I. (2013) · Neurochemistry International · doi:10.1016/j.neuint.2012.08.014 · Cited by 436
Metals and amyloid‐β in Alzheimer's disease
Maynard, C. J., Bush, A. I., Masters, C. L., Cappai, R., & Li, Q. (2005) · International Journal of Experimental Pathology · doi:10.1111/j.0959-9673.2005.00434.x · Cited by 353
“…increased serum and CSF Cu levels (Basun et al. 1991; Gonzalez et al. 1999; Squitti et al. 2002) and decreased serum Fe and Zn (Loeffler et al. 1994; Molina et al. 1998), suggesting a redistribution of metals between the brain and the fluids responsible for supplying and clearing excreted metals…”
BackgroundOxidative stress in Alzheimer's disease
Chauhan, V., & Chauhan, A. (2006) · Pathophysiology · doi:10.1016/j.pathophys.2006.05.004 · Cited by 342
Oxidative stress in blood in Alzheimer's disease and mild cognitive impairment: A meta-analysis
Schrag, M., Mueller, C., Zabel, M., Crofton, A., Kirsch, W. M., Ghribi, O., Squitti, R., & Perry, G. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2013.07.005 · Cited by 336
“8% (Agarwal et al., 2008; Arnal et al., 2010; Baum et al., 2010; Brewer et al., 2010; Cristalli et al., 2012; Gerhardsson et al., 2008; Gonzalez et al., 1999; Jeandel et al., 1989; Kapaki et al., 1989; Molaschi et al., 1996; Molina et al., 1998; Mueller et al., 2012; Sedighi et al., 2006; Sevim et al., 2007; Shore et…”
Manganese Dosimetry: Species Differences and Implications for Neurotoxicity
Aschner, M., Erikson, K. M., & Dorman, D. C. (2005) · Critical Reviews in Toxicology · doi:10.1080/10408440590905920 · Cited by 326
Plasma nutrient status of patients with Alzheimer's disease: Systematic review and meta‐analysis
Lopes da Silva, S., Vellas, B., Elemans, S., Luchsinger, J., Kamphuis, P., Yaffe, K., Sijben, J., Groenendijk, M., & Stijnen, T. (2014) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2013.05.1771 · Cited by 311
“05 [39,51] 3 studies [53,129,142] Zinc 5 studies [39,51,53,142,143] 157 554 2 studies P , .”
InfluentialAtwood, C. S., Obrenovich, M. E., Liu, T., Chan, H., Perry, G., Smith, M. A., & Martins, R. N. (2003) · Brain Research Reviews · doi:10.1016/s0165-0173(03)00174-7 · Cited by 293
Brain manganese and the balance between essential roles and neurotoxicity
Balachandran, R. C., Mukhopadhyay, S., McBride, D., Veevers, J., Harrison, F. E., Aschner, M., Haynes, E. N., & Bowman, A. B. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.rev119.009453 · Cited by 290
“Epidemiological data from human AD and MCI studies are more equivocal and dependent on methods and sample type but support the role for altered Mn accumulation in AD brains (247, 248).”
BackgroundHomeostasis and metabolism of iron and other metal ions in neurodegenerative diseases
Chen, L., Shen, Q., Liu, Y., Zhang, Y., Sun, L., Ma, X., Song, N., & Xie, J. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02071-0 · Cited by 242
Copper and Oxidative Stress in the Pathogenesis of Alzheimer’s Disease
Eskici, G., & Axelsen, P. H. (2012) · Biochemistry · doi:10.1021/bi3006169 · Cited by 290
Zinc homeostasis and neurodegenerative disorders
Szewczyk, B. (2013) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2013.00033 · Cited by 288
Biological metals and Alzheimer's disease: Implications for therapeutics and diagnostics
Duce, J. A., & Bush, A. I. (2010) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2010.04.003 · Cited by 283
Brain, aging and neurodegeneration: Role of zinc ion availability
Mocchegiani, E., Bertoni-Freddari, C., Marcellini, F., & Malavolta, M. (2005) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2005.04.005 · Cited by 283
Metals and neurodegenerative diseases. A systematic review
Cicero, C. E., Mostile, G., Vasta, R., Rapisarda, V., Signorelli, S. S., Ferrante, M., Zappia, M., & Nicoletti, A. (2017) · Environmental Research · doi:10.1016/j.envres.2017.07.048 · Cited by 269
Zinc takes the center stage: its paradoxical role in Alzheimer’s disease
Cuajungco, M. P., & Fagét, K. Y. (2003) · Brain Research Reviews · doi:10.1016/s0165-0173(02)00219-9 · Cited by 242
Pivotal role of glycogen synthase kinase-3: A therapeutic target for Alzheimer's disease
Maqbool, M., Mobashir, M., & Hoda, N. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2015.10.018 · Cited by 227
Berg, D., Youdim, M. B. H., & Riederer, P. (2004) · Cell and Tissue Research · doi:10.1007/s00441-004-0976-5 · Cited by 220
Antioxidant strategies for Alzheimer's disease
Grundman, M., & Delaney, P. (2002) · Proceedings of the Nutrition Society · doi:10.1079/pns2002146 · Cited by 191
Brain Iron Metabolism Dysfunction in Parkinson’s Disease
Jiang, H., Wang, J., Rogers, J., & Xie, J. (2017) · Molecular Neurobiology · doi:10.1007/s12035-016-9879-1 · Cited by 180
Copper in Alzheimer's Disease: A Meta-Analysis of Serum, Plasma, and Cerebrospinal Fluid Studies
Bucossi, S., Ventriglia, M., Panetta, V., Salustri, C., Pasqualetti, P., Mariani, S., Siotto, M., Rossini, P. M., & Squitti, R. (2011) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-101473 · Cited by 182
“Standardized mean difference (SMD) computed from the studies on Cu serum levels ( mol/L) [7–9, 11–22].”
Excess of nonceruloplasmin serum copper in AD correlates with MMSE, CSF β-amyloid, and h-tau
Squitti, R., Barbati, G., Rossi, L., Ventriglia, M., Dal Forno, G., Cesaretti, S., Moffa, F., Caridi, I., Cassetta, E., Pasqualetti, P., et al. (2006) · Neurology · doi:10.1212/01.wnl.0000223343.82809.cf · Cited by 180
Copper in Alzheimer's Disease: A Meta-Analysis of Serum, Plasma, and Cerebrospinal Fluid Studies
Ventriglia, M., Bucossi, S., Panetta, V., & Squitti, R. (2012) · Journal of Alzheimer's Disease · doi:10.3233/jad-2012-120244 · Cited by 180
Excess of serum copper not related to ceruloplasmin in Alzheimer disease
Squitti, R., Pasqualetti, P., Dal Forno, G., Moffa, F., Cassetta, E., Lupoi, D., Vernieri, F., Rossi, L., Baldassini, M., & Rossini, P. M. (2005) · Neurology · doi:10.1212/01.wnl.0000154531.79362.23 · Cited by 167
Metal Ion Physiopathology in Neurodegenerative Disorders
Bolognin, S., Messori, L., & Zatta, P. F. (2009) · NeuroMolecular Medicine · doi:10.1007/s12017-009-8102-1 · Cited by 170
Zinc and copper modulate Alzheimer Aβ levels in human cerebrospinal fluid
Altschul, D., Launer, L. J., Adlard, P. A., Cherny, R. A., Tsatsanis, A., Volitakis, I., Blennow, K., Petrovitch, H., White, L. R., & Bush, A. I. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.10.012 · Cited by 166
“One study reported a significant elevation of copper [3], a second study described decreased zinc levels in living AD subjects [30].”
BackgroundAβ as a bioflocculant: implications for the amyloid hypothesis of Alzheimer’s disease
Robinson, S. R., & Bishop, G. M. (2002) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00342-6 · Cited by 173
Alzheimer’s disease: How metal ions define β-amyloid function
Kepp, K. P. (2017) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2017.05.007 · Cited by 150
Lower brain and blood nutrient status in Alzheimer's disease: Results from meta‐analyses
de Wilde, M. C., Vellas, B., Girault, E., Yavuz, A. C., & Sijben, J. W. (2017) · Alzheimer's & Dementia: Translational Research & Clinical Interventions · doi:10.1016/j.trci.2017.06.002 · Cited by 135
“[141]), and manganese (three studies [123,135,137]).”
Li, D., Zhang, W., Wang, Z., & Zhao, P. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00300 · Cited by 146
“…1999) and neurons with neurofibrillary tangles (Gonzalez-Dominguez et al., 2014), bind with the ironresponsive element RNA stem loop in the 5′-UTR of amyloidβ protein precursor (AβPP) mRNA, and then regulate the translation of AβPP (Molina et al., 1998; Squitti et al., 2013b) and AD progression.”
BackgroundSubclinical Zinc Deficiency in Alzheimer’s Disease and Parkinson’s Disease
Brewer, G. J., Kanzer, S. H., Zimmerman, E. A., Molho, E. S., Celmins, D. F., Heckman, S. M., & Dick, R. (2010) · American Journal of Alzheimer's Disease & Other Dementias® · doi:10.1177/1533317510382283 · Cited by 136
Meta-Analysis of Serum Non-Ceruloplasmin Copper in Alzheimer's Disease
Squitti, R., Simonelli, I., Ventriglia, M., Siotto, M., Pasqualetti, P., Rembach, A., Doecke, J., & Bush, A. I. (2013) · Journal of Alzheimer’s Disease · doi:10.3233/jad-131247 · Cited by 132
“Additionally, we compared Adj-Cp copper in the meta-analysis incorporating data from14 studies (Tables 1 and 2), and total copper in a meta-analysis including data from 27 studies [14–20, 22–27, 31–44] (Table 3).”
MethodTao, Y., Wang, Y., Rogers, J. T., & Wang, F. (2014) · Journal of Alzheimer's Disease · doi:10.3233/jad-140396 · Cited by 134
“All the included studies reported the iron concentrations in both healthy controls and AD patients [27–44, 47, 50–73].”
Hegde, M. L., Shanmugavelu, P., Vengamma, B., Rao, T. S., Menon, R. B., Rao, R. V., & Rao, K. S. J. (2004) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2004.09.003 · Cited by 137
Potential roles of zinc in the pathophysiology and treatment of major depressive disorder
Swardfager, W., Herrmann, N., McIntyre, R. S., Mazereeuw, G., Goldberger, K., Cha, D. S., Schwartz, Y., & Lanctôt, K. L. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2013.03.018 · Cited by 116
Rana, M., & Sharma, A. K. (2019) · Metallomics · doi:10.1039/c8mt00203g · Cited by 122
Arnal, N., Cristalli, D. O., de Alaniz, M. J. T., & Marra, C. A. (2009) · Brain Research · doi:10.1016/j.brainres.2009.11.085 · Cited by 123
Wang, Z.-X., Tan, L., Wang, H.-F., Ma, J., Liu, J., Tan, M.-S., Sun, J.-H., Zhu, X.-C., Jiang, T., & Yu, J.-T. (2015) · Journal of Alzheimer's Disease · doi:10.3233/jad-143108 · Cited by 112
Sparks, D. L., Friedland, R. P., Petanceska, S. S., Schreurs, B. G., Shi, J., Perry, G. L., Smith, M. A., Sharma, A., DeRosa, S., Ziolkowski, C. H. J., et al. (2006) · PubMed · Cited by 124
Pelizzoni, I., Macco, R., Morini, M. F., Zacchetti, D., Grohovaz, F., & Codazzi, F. (2011) · Aging Cell · doi:10.1111/j.1474-9726.2010.00652.x · Cited by 113
“…of Fe2+ is released by dying erythrocytes (Wu et al., 2003; Gaasch et al., 2007b), we provide evidence that also concentrations of Fe2+ as low as 1 lM (concentrations measured in the cerebrospinal fluid; see Molina et al., 1998; Bradbury, 1997) are effective in promoting intracellular iron load.”
BackgroundInfluentialCalcium, copper, iron, magnesium, silicon and zinc content of hair in Parkinson's disease
Forte, G., Alimonti, A., Violante, N., Gregorio, M. D., Senofonte, O., Petrucci, F., Sancesario, G., & Bocca, B. (2005) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2005.08.003 · Cited by 117
Selective destabilization of soluble amyloid β oligomers by divalent metal ions
Garai, K., Sengupta, P., Sahoo, B., & Maiti, S. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.04.056 · Cited by 102
New Insights on the Role of Manganese in Alzheimer’s Disease and Parkinson’s Disease
Martins, A. C., Morcillo, P., Ijomone, O. M., Venkataramani, V., Harrison, F. E., Lee, E.-S., Bowman, A. B., & Aschner, M. (2019) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph16193546 · Cited by 110
Distinctive Pattern of Serum Elements During the Progression of Alzheimer’s Disease
Paglia, G., Miedico, O., Cristofano, A., Vitale, M., Angiolillo, A., Chiaravalle, A. E., Corso, G., & Costanzo, A. D. (2016) · Scientific Reports · doi:10.1038/srep22769 · Cited by 99
Zinc in Alzheimer’s Disease: A Meta-Analysis of Serum, Plasma, and Cerebrospinal Fluid Studies
Ventriglia, M., Brewer, G. J., Simonelli, I., Mariani, S., Siotto, M., Bucossi, S., & Squitti, R. (2015) · Journal of Alzheimer's Disease · doi:10.3233/jad-141296 · Cited by 94
Manganese, Copper, and Zinc in Cerebrospinal Fluid from Patients with Multiple Sclerosis
Melø, T. M., Larsen, C. B., White, L. R., Aasly, J. O., Sjøbakk, T. E., Flaten, T. P., Sonnewald, U., & Syversen, T. L. M. (2003) · Biological Trace Element Research · doi:10.1385/bter:93:1-3:1 · Cited by 95
Lovell, M. A. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-0992 · Cited by 87
Copper and iron in Alzheimer's disease: a systematic review and its dietary implications
Loef, M., & Walach, H. (2011) · British Journal Of Nutrition · doi:10.1017/s000711451100376x · Cited by 95
“Reports on systemic levels of Fe in subjects with AD are inconsistent; two studies found decreased plasma Fe levels((61,62)), whereas others found unchanged concentrations in CSF and serum compared with controls((63,64,93)).”
BackgroundResultInfluentialIron entry in neurons and astrocytes: a link with synaptic activity
Codazzi, F., Pelizzoni, I., Zacchetti, D., & Grohovaz, F. (2015) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2015.00018 · Cited by 85
“Within this general framework, iron uptake strongly depends on its availability that can vary with age and in some neurodegenerative diseases (Bradbury, 1997; Molina et al., 1998).”
BackgroundPlasma Mineral Content in Type-2 Diabetic Patients and Their Association with the Metabolic Syndrome
Aguilar, M. V., Saavedra, P., Arrieta, F., Mateos-Vega, C. J., González‐Muñoz, M. J., Meseguer, I., & Martínez‐Para, M. C. (2007) · Annals of Nutrition and Metabolism · doi:10.1159/000108108 · Cited by 83
Self-citationFree Copper Distinguishes Mild Cognitive Impairment Subjects from Healthy Elderly Individuals
Squitti, R., Ghidoni, R., Scrascia, F., Benussi, L., Panetta, V., Pasqualetti, P., Moffa, F., Bernardini, S., Ventriglia, M., Binetti, G. G., et al. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-101098 · Cited by 86
“Other studies have reported no variation [19–26].”
Metals in alzheimer's disease: a systemic perspective
Squitti, R. (2011) · Frontiers in bioscience · doi:10.2741/3938 · Cited by 88
“In fact, many studies have reported an increase of circulating copper in AD patients with respect to healthy controls (61-63, 65, 7885), many others no variation (26, 86-94), and two very recent studies even a decrease of plasma (27) and serum (95) copper in AD patients.”
BackgroundHazlett, K. R. O., Rusnak, F., Kehres, D. G., Bearden, S. W., La Vake, C. J., La Vake, M. E., Maguire, M. E., Perry, R. D., & Radolf, J. D. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300781200 · Cited by 78
Toward a Rational Design to Regulate β-Amyloid Fibrillation for Alzheimer’s Disease Treatment
Han, X., & He, G. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.7b00477 · Cited by 81
Zinc Deficiency Is Common in Several Psychiatric Disorders
Grønli, O., Kvamme, J., Friborg, O., & Wynn, R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0082793 · Cited by 78
“This result is in line with other studies that revealed no significant differences in serum zinc levels between controls and AD patients [16,17,33].”
Du, K., Liu, M., Pan, Y., Zhong, X., & Wei, M. (2017) · Nutrients · doi:10.3390/nu9030231 · Cited by 70
“78 ICP-AES Molina 1998 [33] Spain 26 46 73.”
Synaptic Zinc: An Emerging Player in Parkinson’s Disease
Sikora, J., & Ouagazzal, A.-M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094724 · Cited by 73
Inoue, K., O’Bryant, Z., & Xiong, Z.-G. (2015) · Current Medicinal Chemistry · doi:10.2174/0929867322666150209153750 · Cited by 69
Features of ceruloplasmin in the cerebrospinal fluid of Alzheimer’s disease patients
Capo, C. R., Arciello, M., Squitti, R., Cassetta, E., Rossini, P. M., Calabrese, L., & Rossi, L. C. (2007) · BioMetals · doi:10.1007/s10534-007-9125-4 · Cited by 74
“The level of copper in this patients is close to the value obtained in other studies (Molina et al. 1998; Melo et al. 2003; Squitti et al. 2006).”
Decreased Copper in Alzheimer’s Disease Brain Is Predominantly in the Soluble Extractable Fraction
Rembach, A., Hare, D. J., Lind, M., Fowler, C. J., Cherny, R. A., McLean, C., Bush, A. I., Masters, C. L., & Roberts, B. R. (2013) · International Journal of Alzheimer s Disease · doi:10.1155/2013/623241 · Cited by 79
“Alzheimer’s disease (AD) is the predominant cause of dementia in the aging population and represents a mounting health epidemic [1].”
BackgroundAmyloid-β Metal Interaction and Metal Chelation
Cuajungco, M. P., Frederickson, C. J., & Bush, A. I. (2006) · Springer eBooks · doi:10.1007/0-387-23226-5_12 · Cited by 72
Elevated manganese levels in blood and CNS in human prion disease
Hesketh, S., Sassoon, J., Knight, R., & Brown, D. R. (2008) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2007.12.008 · Cited by 68
Iron Pathophysiology in Alzheimer’s Diseases
Wang, T., Xu, S.-F., Fan, Y.-G., Li, L.-B., & Guo, C. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-9589-5_5 · Cited by 64
Leko, M. B., Horvat, L. L., Španić, E., Zubčić, K., Hof, P. R., & Šimić, G. (2023) · Biomedicines · doi:10.3390/biomedicines11041161 · Cited by 72
Redox Imbalance and Viral Infections in Neurodegenerative Diseases
Limongi, D., & Baldelli, S. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/6547248 · Cited by 62
“Similarly, catalase and glutathione reductase activity, as well as GSH levels, were found to be significantly reduced in ALS patients [19].”
BackgroundManganese in cerebrospinal fluid and blood plasma of patients with amyotrophic lateral sclerosis
Roos, P. M., Lierhagen, S., Flaten, T. P., Syversen, T. L. M., Vesterberg, O., & Nordberg, M. (2012) · Experimental Biology and Medicine · doi:10.1258/ebm.2012.011396 · Cited by 66
Ceruloplasmin fragmentation is implicated in 'free' copper deregulation of Alzheimer disease
Squitti, R., Quattrocchi, C. C., Salustri, C., & Rossini, P. M. (2008) · Prion · doi:10.4161/pri.2.1.6297 · Cited by 69
Solovyev, N. D., Vinceti, M., Grill, P., Mandrioli, J., & Michalke, B. (2017) · Analytica Chimica Acta · doi:10.1016/j.aca.2017.03.040 · Cited by 63
Costa‐Mallen, P., Gatenby, C., Friend, S., Maravilla, K. R., Hu, S., Cain, K. C., Agarwal, P., & Anzai, Y. (2017) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2017.04.035 · Cited by 68
Mild Cognitive Impairment and Alzheimer Patients Display Different Levels of Redox-Active CSF Iron
Lavados, M., Guillón, M., Mujica, M. C., Rojo, L. E., Fuentes, P., & Maccioni, R. B. (2008) · Journal of Alzheimer's Disease · doi:10.3233/jad-2008-13211 · Cited by 61
“[46].”
Solfrizzi, V., Colacicco, A. M., D'Introno, A., Capurso, C., Parigi, A. D., Capurso, S. A., Torres, F., Capurso, A., & Panza, F. (2006) · Journal of Alzheimer's Disease · doi:10.3233/jad-2006-102-314 · Cited by 60
Monitoring of chemical elements and oxidative damage in patients affected by Alzheimer's disease.
Bocca, B., Forte, G., Petrucci, F., Pino, A., Marchione, F., Bomboi, G., Senofonte, O., Giubilei, F., & Alimonti, A. (2005) · PubMed · Cited by 64
Michalke, B., Berthele, A., Mistriotis, P., Ochsenkühn-Petropoulou, M. T., & Halbach, S. (2007) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2007.09.004 · Cited by 61
Zinc diet and Alzheimer's disease: a systematic review
Loef, M., von Stillfried, N., & Walach, H. (2012) · Nutritional Neuroscience · doi:10.1179/1476830512y.0000000010 · Cited by 56
Serum Zinc in the Progression of Alzheimer's Disease
Dong, J., Robertson, J. D., Markesbery, W. R., & Lovell, M. A. (2008) · Journal of Alzheimer s Disease · doi:10.3233/jad-2008-15310 · Cited by 65
“Our current data are consistent with previous studies [32,47,63] that showed no significant differences between control and AD serum Zn levels but are in contrast to our previous study of postmortem serum from a small number of LAD and control subjects [59] when subjects of both sexes were combined.”
CSF Mg and Ca as diagnostic markers for dementia with Lewy bodies
Boström, F., Hansson, O., Gerhardsson, L., Lundh, T., Minthon, L., Stomrud, E., Zetterberg, H., & Londos, E. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.10.018 · Cited by 58
Trace elements and Alzheimer dementia in population-based studies: A bibliometric and meta-analysis
Li, K., Li, A., Mei, Y., Zhao, J., Zhou, Q., Li, Y., Yang, M., & Xu, Q. (2022) · Environmental Pollution · doi:10.1016/j.envpol.2022.120782 · Cited by 56
Longitudinal Analysis of Serum Copper and Ceruloplasmin in Alzheimer's Disease
Rembach, A., Doecke, J. D., Roberts, B. R., Watt, A. D., Faux, N. G., Volitakis, I., Pertile, K. K., Rumble, R. L., Trounson, B. O., Fowler, C. J., et al. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-121474 · Cited by 52
“This finding is consistent with a number of previous studies [18–20], which independently support our results, although they were composed of relatively less subjects and used different analytical techniques to measure copper and CP.”
Toxicity of copper salts is dependent on solubility profile and cell type tested
Shaligram, S. S., & Campbell, A. (2012) · Toxicology in Vitro · doi:10.1016/j.tiv.2012.12.026 · Cited by 53
Sanyal, J., Ahmed, S. S. S. J., Ng, H. K. T., Naiya, T., Ghosh, E., Banerjee, T. K., Lakshmi, J. J., Guha, G., & Rao, V. R. (2016) · Scientific Reports · doi:10.1038/srep35097 · Cited by 53
Jomová, K., Alomar, S. Y., Valko, R., Nepovimová, E., Kuča, K., & Valko, M. (2025) · EXCLI journal · doi:10.17179/excli2025-8449 · Cited by 160
Decreased serum zinc is an effect of ageing and not Alzheimer's disease
Rembach, A., Hare, D. J., Doecke, J. D., Burnham, S. C., Volitakis, I., Fowler, C. J., Cherny, R. A., McLean, C., Grimm, R., Martins, R. N., et al. (2014) · Metallomics · doi:10.1039/c4mt00060a · Cited by 54
Overdosing on iron: Elevated iron and degenerative brain disorders
D’Mello, S. R., & Kindy, M. S. (2020) · Experimental Biology and Medicine · doi:10.1177/1535370220953065 · Cited by 52
Elevated serum copper and ceruloplasmin levels in Alzheimer's disease
Park, J., Lee, D. W., & Park, K. S. (2013) · Asia-Pacific Psychiatry · doi:10.1111/appy.12077 · Cited by 52
“Copper ions are closely involved in several human neurodegenerative disorders (Molina et al., 1998; Ozcankaya and Delibas, 2002), with their involvement being especially well documented in Parkinson’s disease (PD) (Squitti et al., 2005).”
BackgroundManganese speciation in human cerebrospinal fluid using CZE coupled to inductively coupled plasma MS
Michalke, B., Berthele, A., Mistriotis, P., Ochsenkühn-Petropoulou, M. T., & Halbach, S. (2007) · Electrophoresis · doi:10.1002/elps.200600686 · Cited by 53
Gerhardsson, L., Blennow, K., Lundh, T., Londos, E., & Minthon, L. (2009) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000233353 · Cited by 46
“Zn concentrations in CSF can be significantly reduced in subjects with AD in comparison with controls [”
ResultGene-Environment Interaction Research and Transgenic Mouse Models of Alzheimer's Disease (Erratum)
Chouliaras, L., Sierksma, A. S. R., Kenis, G., Prickaerts, J., Lemmens, M. A. M., Brasnjevic, I., van Donkelaar, E. L., Martinez-Martinez, P., Losen, M., De Baets, M. H., et al. (2010) · International Journal of Alzheimer's Disease · doi:10.4061/2010/356862 · Cited by 44
“AD patients displaying higher levels of zinc in hippocampus and amygdala [125, 126] exhibited normal zinc serum levels, but significantly lower zinc levels in CSF compared to matched controls [134].”
ResultCopper mediated amyloid-β binding to Transthyretin
Ciccone, L., Fruchart‐Gaillard, C., Mourier, G., Savko, M., Nencetti, S., Orlandini, E., Servent, D., Stura, E. A., & Shepard, W. (2018) · Scientific Reports · doi:10.1038/s41598-018-31808-5 · Cited by 40
Scholefield, M., Unwin, R. D., & Cooper, G. J. S. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101152 · Cited by 39
Iron and Parkinson's disease: A systematic review and meta-analysis
Mostile, G., Cicero, C. E., Giuliano, L., Zappia, M., & Nicoletti, A. S. Q. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.6386 · Cited by 39
Copper in Alzheimer’s disease: too much or too little?
Quinn, J. F., Crane, S., Harris, C., & Wadsworth, T. L. (2009) · Expert Review of Neurotherapeutics · doi:10.1586/ern.09.27 · Cited by 38
Potential Blood Biomarker for Disease Severity in the Taiwanese Population With Alzheimer’s Disease
Huang, C.-W., Wang, S.-J., Wu, S.-J., Yang, C.-C., Huang, M.-W., Lin, C.-H., & Cheng, I. H. (2013) · American Journal of Alzheimer's Disease & Other Dementias® · doi:10.1177/1533317512467674 · Cited by 37
“Plasma samples were analyzed for total Ab, Ab42, IL-6, and TNF-a by specific commercial plate-based enzyme-linked immunosorbant assays (ELISAs): (1) Human Ab (1 , 1-42) Assay Kit (IBL, Minnesota), (2) Human TNF-a Quantikine Kit (R&D Systems, Minnesota), and (3) Human IL-6 Quantikine Kit (R&D Systems).”
MethodSparks, D. L. (2004) · Journal of Molecular Neuroscience · doi:10.1385/jmn:24:1:097 · Cited by 37
Zheng, G., Chen, J., & Zheng, W. (2012) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2012.03.006 · Cited by 39
Neurodegenerative Memory Disorders: A potential Role of Environmental Toxins
Caban‐Holt, A., Mattingly, M., Cooper, G. E., & Schmitt, F. A. (2005) · Neurologic Clinics · doi:10.1016/j.ncl.2004.12.005 · Cited by 36
“Molina et al [85] ascertained serum and cerebrospinal fluid (CSF) levels of numerous metals in 26 patients with AD and 28 matched controls.”
BackgroundMetal attenuating therapies in neurodegenerative disease
Mot, A. I., Wedd, A. G., Sinclair, L., Brown, D. R., Collins, S. J., & Brazier, M. W. (2011) · Expert Review of Neurotherapeutics · doi:10.1586/ern.11.170 · Cited by 35
Association between the c. 2495 A>G ATP7B Polymorphism and Sporadic Alzheimer′s Disease
Bucossi, S., Mariani, S., Ventriglia, M., Polimanti, R. A., Gennarelli, M., Bonvicini, C., Pasqualetti, P., Scrascia, F., Migliore, S., Vernieri, F., et al. (2011) · International Journal of Alzheimer s Disease · doi:10.4061/2011/973692 · Cited by 31
Willkommen, D., Lucio, M., Schmitt‐Kopplin, P., Gazzaz, M., Schroeter, M., Sigaroudi, A., & Michalke, B. (2018) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2018.01.005 · Cited by 31
Kodali, P., Chitta, K. R., Figueroa, J. A. L., Caruso, J. A., & Adeoye, O. M. (2012) · Metallomics · doi:10.1039/c2mt20092a · Cited by 35
Gene-Environment Interaction Research and Transgenic Mouse Models of Alzheimer's Disease
Chouliaras, L., Sierksma, A. S. R., Kenis, G., Prickaerts, J., Lemmens, M. A. M., Brasnjevic, I., van Donkelaar, E. L., Martinez-Martinez, P., Losen, M., De Baets, M. H., et al. (2010) · International Journal of Alzheimer's Disease · doi:10.4061/2010/859101 · Cited by 30
“AD patients displaying higher levels of zinc in hippocampus and amygdala [125, 126] exhibited normal zinc serum levels, but significantly lower zinc levels in CSF compared to matched controls [134].”
Result
Metadata
- Authors
- Molina, J. A., Jiménez-Jiménez, F. J., Aguilar, M. V., Meseguer, I., Mateos-Vega, C. J., González-Muñoz, M. J., de Bustos, F., Porta, J., Ortí-Pareja, M., Zurdo, M., Barrios, E., & Martínez-Para, M. C.
- Affiliations
- Hospital Universitario 12 De Octubre (ES)
- Hospital Universitario Príncipe de Asturias (ES)
- Universidad de Alcalá (ES)
- Venue
- Journal of Neural Transmission
- Published
- 1998
- Volume
- 105
- Issue
- 4
- Pages
- 479
- ISSN
- 0300-9564 (ISSN-L)
- OpenAlex
- W2007947235
- Cited by
- 167
- References
- 50
- Citations by year
- 2026: 2 · 2025: 1 · 2024: 3 · 2023: 2 · 2022: 5 · 2021: 5 · 2020: 5 · 2019: 3 · 2018: 5 · 2017: 14 · 2016: 6 · 2015: 6 · 2014: 5 · 2013: 15 · 2012: 12
- FWCI
- 0.36
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Journal of Neural Transmission (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Trace Elements in Health
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- Alzheimer's disease, cerebrospinal fluid, transition metals, zinc, iron, copper, manganese, serum metal levels, metal deficiency, amyloid-beta, amyloid precursor protein, body mass index, malnutrition
- MeSH terms
- Aged, Alzheimer Disease, Blood Proteins, Copper, Female, Humans, Iron, Male, Manganese, Nutritional Status, Reference Values, Spectrophotometry, Atomic, Trace Elements, Vitamin A, Zinc, Metals, Heavy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.